Agilent
CombinatoRx
Dynogen
GulfStream
Harvard-MIT HST
High Acre Systems
Hypnion
Idera Pharmaceuticals
Massachusetts Biotechnology Council
MassBiotech 2010 Report
Neuco
Synta Pharmaceuticals
Verenium
Veridocs
Xanthus Pharmaceuticals
The second annual report for CombinatoRx, reflects the company’s accelerated pipeline developed with proprietary technology.
print | web site
2007 ANNUAL REPORT
2008 ANNUAL REPORT
CLINICAL TRIALS MARKETING CAMPAIGN
Campaign in multiple languages for CRX-102 in Osteoarthritis and Rheumatoid Arthritis.
WEB SITE
